Eptifibatide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Eptifibatide and local guidelines before prescribing.

Glycoprotein IIb/IIIa inhibitor

Mechanism

Glycoprotein IIb/IIIa inhibitor.

Uses

Acute coronary syndrome, PCI.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Bleeding, thrombocytopenia.

Interactions

Anticoagulants and antiplatelets.

Contraindications and cautions

Active bleeding, severe hypertension

Monitoring

Platelets, bleeding

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose if CrCl below 50

Overdose and reversal

Platelet transfusion

Special advice

Used in high-risk NSTEMI before PCI.

More from the textbook: uses, cautions and other points
Where it is discussed in the book